Menlo Park, CA, United States of America

Cary J Reich

USPTO Granted Patents = 129 

 

Average Co-Inventor Count = 4.8

ph-index = 25

Forward Citations = 2,552(Granted Patents)


Inventors with similar research interests:


Location History:

  • Irvine, CA (US) (1991 - 1992)
  • Laguna Hills, CA (US) (1990 - 2000)
  • Parsippany, NJ (US) (2020 - 2022)
  • Menlo Park, CA (US) (2012 - 2023)
  • South San Francisco, CA (US) (2023)
  • San Francisco, CA (US) (2023)
  • Los Gatos, CA (US) (2002 - 2024)
  • Santa Barbara, CA (US) (2018 - 2024)
  • Brisbane, CA (US) (2021 - 2024)

Company Filing History:

goldMedal23 out of 50 
 
Forsight Vision4, Inc.
 patents
silverMedal19 out of 19 
 
Nexisvision, Inc.
 patents
bronzeMedal17 out of 2,480 
 
Baxter International Inc.
 patents
416 out of 1,149 
 
Baxter Healthcare Sa
 patents
515 out of 37 
 
Mati Therapeutics Inc.
 patents
610 out of 10 
 
Forsight Vision5, Inc.
 patents
78 out of 11 
 
Forsight Labs, LLC
 patents
87 out of 19 
 
Azura Ophthalmics Ltd.
 patents
96 out of 7 
 
Journey1, Inc.
 patents
105 out of 8 
 
Chiron Ophthalmics, Inc.
 patents
115 out of 15 
 
Forsight Vision6, Inc.
 patents
123 out of 53 
 
The Foundry, Inc.
 patents
132 out of 14 
 
Fusion Medical Technologies, Inc.
 patents
142 out of 2 
 
M.g. Therapeutics, Ltd.
 patents
151 out of 24 
 
Baxter Healthcare Inc.
 patents
161 out of 35 
 
Qlt Inc.
 patents
171 out of 231 
 
Surmodics, Inc.
 patents
181 out of 1 
 
Dean A. Mcgee Eye Inst.
 patent
191 out of 37 
 
Transcend Medical, Inc.
 patents
201 out of 3,923 
 
Novartis Ag
 patents
212 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1990-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Meibomian Gland Dysfunction
Nasolacrimal Drainage Implants
Intraocular Accommodating Lens
Contact Lenses
Drug Delivery Methods
Ocular Inserts
Therapeutic Agent Formulations
Hemostatic Compositions
Corneal Denervation
Ophthalmic Drug Release
Pain Management Devices
Multifocal Bimodulus Lenses
129 patents (USPTO):Explore Patents

**Title: Innovations of Cary J Reich: Advancements in Medical Technology**

Introduction

Cary J Reich, based in Menlo Park, CA, is an esteemed inventor known for his significant contributions to medical technology. With an impressive portfolio of 127 patents, his work has impacted various fields, particularly in ophthalmology and hemostatic compositions.

Latest Patents

Among his latest innovations, Cary has developed novel solutions such as the nasolacrimal drainage system implants for drug therapy. This implant is designed for insertion through a punctum into the canalicular lumen of a patient, featuring a matrix of material infused with a therapeutic agent. Notably, the design includes a sheath to control the release of the agent to the tear film, ensuring effective therapy administration. Another noteworthy invention is a process for creating dry and stable hemostatic compositions, which has broadened the possibilities for medical treatments requiring effective hemostatic solutions.

Career Highlights

Cary has had an impactful career with leading companies in the medical technology sector. He has made significant strides while working at Forsight Vision4, Inc. and Nexisvision, Inc., where his skills in innovation have led to substantial advancements in healthcare solutions.

Collaborations

Throughout his career, Cary has collaborated with notable professionals in the field, including Eugene de Juan, Jr. and Yair Alster. Their collective expertise has fostered an environment of creativity and innovation, resulting in the development of cutting-edge medical technologies.

Conclusion

Cary J Reich exemplifies the spirit of innovation, with a remarkable track record of patents that contribute to advancing medical therapies. His inventions, especially in the realms of drug delivery and hemostasis, highlight the importance of inventive thinking in improving patient care and outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…